< Arab Finance - News - Rameda to launch new antithrombotic drug
Count Down to relaunch

Rameda to launch new antithrombotic drug

Rameda to launch new antithrombotic drug

ArabFinance: Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) signed a strategic partnership to purchase a new antithrombotic drug, according to Rameda’s statement filed to the Egyptian Exchange.

This is the largest acquisition of its kind in the history of the company, Rameda said.

The listed company’s extraordinary general assembly ratified issued capital increase by EGP 57.850 million.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.

#Related keywords


Recommended Stocks

04 Oct 2021
United Housing & Development UNIT

All rights reserved to Arab Finance 2020 ©

Back to top